Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5e253804-c186-4329-8509-97ba1ad8d714
Date 11/2/2016
Company Name Biohaven
Mailing Address 234 Church Street New Haven, CT 06510 USA
Company Description Biohaven is a privately-held biopharmaceutical company with particular expertise in late stage clinical development and has portfolio of multiple late stage drug assets. Biohaven has licensed intellectual property from Yale University, Catalent, ALS Biopharma LLC, Massachusetts General Hospital and two undisclosed pharmaceutical companies.
Proceeds Purposes Proceeds from this financing will be used to advance the company’s late stage clinical programs in orphan neurologic indications and other trials in areas of large unmet medical needs. Biohaven plans to initiate Phase 2/3 studies in 4Q2016 and in 2017.